Subjects: Prescription Fees - Digital Collections - National Library of Medicine Search Results

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NLM Digital Collections

Start Over Subjects Prescription Fees

1. How much are Medicare beneficiaries paying out-of-pocket for prescription drugs?

Publication:: Washington, DC : Public Policy Institute, AARP, 1999
Subject(s):: Medicare -- economics
Prescription Fees
Drug Prescriptions -- economics
Insurance Coverage
United States

2. Three states' approaches to pharmaceutical assistance: a guide for the perplexed

Publication:: Washington, DC : AARP Public Policy Institute, 2002
Subject(s):: Insurance, Pharmaceutical Services
Aged
Cost Savings
Medicaid -- economics
Prescription Fees
State Government
California
Maine
New Jersey

3. CMS should bolster its oversight of manufacturer-submitted average sales price data to ensure accurate Part B drug payments

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2022
Subject(s):: Cost Control
Drug Costs
Drug Industry
Government Regulation
Medicare Part B
Prescription Fees
United States
Centers for Medicare & Medicaid Services (U.S.)

4. Manufacturers may need additional guidance to ensure consistent calculations of average sales prices

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2022
Subject(s):: Drug Costs
Drug Industry
Government Regulation
Medicaid
Medicare Part B
Prescription Fees
United States

5. Medicare Part B drug payments: impact of price substitutions based on 2021 average sales prices

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, August 2023
Subject(s):: Cost Control
Drug Costs
Government Regulation
Medicare Part B
Prescription Fees
United States

6. Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: Drug Costs
Government Regulation
Legislation, Medical
Medicare Part D -- economics
Medicare Part D -- organization & administration
Prescription Fees
United States
Centers for Medicare & Medicaid Services (U.S.)